Analysis of sequences required for the cytotoxic action of a chimeric toxin composed of Pseudomonas exotoxin and transforming growth factor alpha
- PMID: 7873657
- DOI: 10.1021/bc00030a008
Analysis of sequences required for the cytotoxic action of a chimeric toxin composed of Pseudomonas exotoxin and transforming growth factor alpha
Abstract
Chimeric toxins composed of transforming growth factor alpha fused to mutant forms of Pseudomonas exotoxin bind to the EGF receptor and kill cells bearing these receptors. In early experiments, the binding domain of Pseudomonas exotoxin was deleted and replaced with TGF alpha to make TGF alpha-PE40. This chimeric toxin required proteolytic processing within the target cell to be converted to its active form (Siegall et al. (1989) FASEB J. 3, 2647-2652). Subsequently, recombinant toxins that do not require proteolytic processing were constructed by inserting TGF alpha near the carboxyl terminus of domain III and deleting toxin residues up to the processing site at position 280. In addition, the carboxyl terminus of this toxin was converted from REDLK to KDEL to increase its activity. Recombinant toxins of this type, termed PE37/TGF alpha/KDEL, are about 100-fold more potent than TGF alpha-PE40. To determine if other sequences can be removed from such chimeric toxins to make a smaller molecule that can penetrate tissues better, we have carried out a deletion analysis of sequences present within domains II and Ib. We find that all of domain Ib and a portion of domain II can be deleted without significant loss of cytotoxic activity, but larger deletions extending further into domain II lose cytotoxic activity. We also find that inserting a small linking peptide (Gly)4Ser between residual sequences in domain II and domain III, in molecules with diminished cytotoxic activity, enhances cytotoxicity suggesting that one role of domain Ib is to prevent undesirable interactions between domains II and III.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Small chimeric toxins containing only transforming growth factor alpha and domain III of Pseudomonas exotoxin with good antitumor activity in mice.Cancer Res. 1994 Oct 1;54(19):5154-9. Cancer Res. 1994. PMID: 7923133
-
Heparin-binding transforming growth factor alpha-Pseudomonas exotoxin A. A heparan sulfate-modulated recombinant toxin cytotoxic to cancer cells and proliferating smooth muscle cells.J Biol Chem. 1993 Mar 5;268(7):4853-62. J Biol Chem. 1993. PMID: 8444864
-
A recombinant form of Pseudomonas exotoxin directed at the epidermal growth factor receptor that is cytotoxic without requiring proteolytic processing.J Biol Chem. 1992 Aug 25;267(24):16872-7. J Biol Chem. 1992. PMID: 1512230
-
Targeting growth factor receptors with fusion toxins.Int J Immunopharmacol. 1992 Apr;14(3):465-72. doi: 10.1016/0192-0561(92)90177-m. Int J Immunopharmacol. 1992. PMID: 1319965 Review.
-
Biophysical characterization and formulation of TP40: A chimeric protein that requires a pH-dependent conformational change for its biological activity.Pharm Biotechnol. 1996;9:365-92. doi: 10.1007/0-306-47452-2_10. Pharm Biotechnol. 1996. PMID: 8914199 Review. No abstract available.
Cited by
-
A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity.Blood. 2009 Apr 16;113(16):3792-800. doi: 10.1182/blood-2008-08-173195. Epub 2008 Nov 6. Blood. 2009. PMID: 18988862 Free PMC article.
-
A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer.FEBS J. 2011 Dec;278(23):4683-700. doi: 10.1111/j.1742-4658.2011.08182.x. Epub 2011 Jun 2. FEBS J. 2011. PMID: 21585657 Free PMC article. Review.
-
EGFR-targeted Chimeras of Pseudomonas ToxA released into the extracellular milieu by attenuated Salmonella selectively kill tumor cells.Biotechnol Bioeng. 2016 Dec;113(12):2698-2711. doi: 10.1002/bit.26026. Epub 2016 Jul 8. Biotechnol Bioeng. 2016. PMID: 27260220 Free PMC article.
-
Improved antitumor activity of a recombinant anti-Lewis(y) immunotoxin not requiring proteolytic activation.Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):974-8. doi: 10.1073/pnas.93.3.974. Proc Natl Acad Sci U S A. 1996. PMID: 8577771 Free PMC article.
-
Crystal structure of the catalytic domain of Pseudomonas exotoxin A complexed with a nicotinamide adenine dinucleotide analog: implications for the activation process and for ADP ribosylation.Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):6902-6. doi: 10.1073/pnas.93.14.6902. Proc Natl Acad Sci U S A. 1996. PMID: 8692916 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources